We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+2.6%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$93.4B
AUM Growth
+$1.44B
Cap. Flow
-$783M
Cap. Flow %
-0.84%
Top 10 Hldgs %
32.36%
Holding
7,324
New
436
Increased
3,303
Reduced
2,734
Closed
395

Sector Composition

Rank Sector Weight
1 Technology 6.12%
2 Healthcare 4.92%
3 Financials 4.07%
4 Consumer Discretionary 3.64%
5 Communication Services 3.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEU icon
6126
Vanguard FTSE All-World ex-US ETF
VEU
$68.5B
$6K ﹤0.01%
113
-361
-76% -$17.9K
WHG icon
6127
Westwood Holdings Group
WHG
$189M
$6K ﹤0.01%
106
-41
-28% -$2.27K
WK icon
6128
Workiva
WK
$3.54B
$6K ﹤0.01%
337
-363
-52% -$6.42K
XNTK icon
6129
State Street SPDR NYSE Technology ETF
XNTK
$2.23B
$6K ﹤0.01%
82
ALPN
6130
DELISTED
Alpine Immune Sciences Inc
ALPN
$6K ﹤0.01%
+675
New +$6.47K
RETA
6131
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$6K ﹤0.01%
194
+16
+9% +$393
TA
6132
DELISTED
TravelCenters of America LLC
TA
$6K ﹤0.01%
289
+196
+211% +$4.72K
SWIR
6133
CALL
DELISTED
Sierra Wireless
SWIR
$6K ﹤0.01%
200
-100
-33% -$2.73K
BRG
6134
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
$6K ﹤0.01%
517
+413
+397% +$5.25K
CNBKA
6135
DELISTED
Century Bancorp Inc/Mass
CNBKA
$6K ﹤0.01%
104
+88
+550% +$5.51K
DNR
6136
PUT
DELISTED
Denbury Resources, Inc.
DNR
$6K ﹤0.01%
3,600
-5,700
-61% -$10.7K
QHC
6137
CALL
DELISTED
Quorum Health Corporation
QHC
$6K ﹤0.01%
1,350
CSS
6138
DELISTED
CSS Industries, Inc.
CSS
$6K ﹤0.01%
258
+16
+7% +$420
ACHN
6139
CALL
DELISTED
Achillion Pharmaceuticals
ACHN
$6K ﹤0.01%
1,200
-8,100
-87% -$32.6K
ACHN
6140
PUT
DELISTED
Achillion Pharmaceuticals
ACHN
$6K ﹤0.01%
1,300
+200
+18% +$804
DNBF
6141
DELISTED
DNB Financial Corp
DNBF
$6K ﹤0.01%
175
-125
-42% -$4.2K
OLBK
6142
DELISTED
Old Line Bancshares, Inc.
OLBK
$6K ﹤0.01%
206
+67
+48% +$1.87K
NVLN
6143
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$6K ﹤0.01%
+694
New +$6.68K
GSOL
6144
DELISTED
Global Sources Ltd
GSOL
$6K ﹤0.01%
305
+195
+177% +$2.81K
ARC
6145
DELISTED
ARC Document Solutions, Inc.
ARC
$6K ﹤0.01%
1,606
+240
+18% +$891
VVUS
6146
PUT
DELISTED
Vivus Inc
VVUS
$6K ﹤0.01%
520
SORL
6147
DELISTED
SORL Auto Parts, Inc.
SORL
$6K ﹤0.01%
+900
New +$5.37K
ANIP icon
6148
CALL
ANI Pharmaceuticals
ANIP
$1.78B
$5K ﹤0.01%
100
-1,000
-91% -$48.2K
ASC icon
6149
Ardmore Shipping
ASC
$683M
$5K ﹤0.01%
620
-9,860
-94% -$76.1K
BSET icon
6150
Bassett Furniture
BSET
$176M
$5K ﹤0.01%
148
+62
+72% +$1.86K

Similar funds

Barclays's Q2 2017 Portfolio in Review

As of Q2 2017, Barclays held 7,324 positions worth $93.4B, up 1.6% from $91.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Barclays's Q2 2017 filing shows 436 new, 3,303 increased, 2,734 reduced and 395 closed positions. Its largest new stake was Altaba Inc: 16,007,195 shares worth $872M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, up from 5.7% a quarter earlier, followed by Healthcare and Financials.

  • Barclays's largest Q2 2017 buy was Altaba Inc: 16,007,195 shares worth $872M.
  • Barclays added most to Invesco QQQ Trust in Q2 2017, an estimated $3.32B increase.
  • Barclays's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
  • Barclays fully exited Yahoo Inc in Q2 2017, selling an estimated $174M.
  • Barclays's ten largest holdings make up 32% of its $93.4B portfolio in Q2 2017.
  • Barclays opened 436 new positions and closed 395 in Q2 2017.
  • Barclays's portfolio value rose 1.6% quarter-over-quarter to $93.4B.

Based on Barclays's 13F filing for Q2 2017, filed 14 Aug 2017.